Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Sarah Goldberg MD, MPH
Sarah B. Goldberg MD, MPH Advisory Board
Guru Sonpavde MD
Guru P. Sonpavde MD Advisory Board
Alexander van Akkooi MD, PhD, FRACS
Alexander C. J. van Akkooi MD, PhD, FRACS Associate Editor
See All Experts
Published in Oncology

News · March 09, 2023

2014 to 2021 Saw Increase in Use of Active Surveillance for Low-Risk Prostate Cancer

Considerable variation observed in active surveillance use, from 4.0 to 78.0 percent at practice level and from 0 to 100 percent at practitioner level

HealthDay

 

 Save  Recommend
 Share

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.

Further Reading

Most Read This Week

Recently Updated